L Laitinen
Overview
Explore the profile of L Laitinen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lesch H, Laitinen A, Peixoto C, Vicente T, Makkonen K, Laitinen L, et al.
Gene Ther
. 2011 Jan;
18(6):531-8.
PMID: 21248790
Lentivirus can be engineered to be a highly potent vector for gene therapy applications. However, generation of clinical grade vectors in enough quantities for therapeutic use is still troublesome and...
2.
Heikkila T, Salonen J, Tuura J, Kumar N, Salmi T, Murzin D, et al.
Drug Deliv
. 2007 Aug;
14(6):337-47.
PMID: 17701523
The feasibility of four mesoporous materials composed of biocompatible Si (TCPSi) or SiO(2) (MCM-41, SBA-15, and TUD-1) were evaluated for oral drug delivery applications. The main focus was to study...
3.
Limnell T, Riikonen J, Salonen J, Kaukonen A, Laitinen L, Hirvonen J, et al.
Int J Pharm
. 2007 Jun;
343(1-2):141-7.
PMID: 17600644
Six different types of mesoporous silicon microparticles were prepared to evaluate the effect of surface treatment and pore sizes on their properties as drug carriers. The studied porous silicon particles...
4.
Heikkila T, Salonen J, Tuura J, Hamdy M, Mul G, Kumar N, et al.
Int J Pharm
. 2006 Oct;
331(1):133-8.
PMID: 17046183
For the first time the feasibility of siliceous mesoporous material TUD-1 (Technische Universiteit Delft) for drug delivery was studied. Model drug, ibuprofen, was adsorbed into TUD-1 mesopores via a soaking...
5.
Salonen J, Laitinen L, Kaukonen A, Tuura J, Bjorkqvist M, Heikkila T, et al.
J Control Release
. 2005 Sep;
108(2-3):362-74.
PMID: 16169628
Mesoporous silicon (PSi) microparticles were produced using thermal carbonization (TCPSi) or thermal oxidation (TOPSi) to obtain surfaces suitable for oral drug administration applications. The loading of five model drugs (antipyrine,...
6.
Ind P, Laitinen L, Laursen L, Wenzel S, Wouters E, Deamer L, et al.
Respir Med
. 2003 Feb;
97 Suppl A:S9-21.
PMID: 12564607
Viozan, (Sibenadet HCl, AR-C68397AA) is a dual D2 dopamine receptor, beta2-adrenoceptor agonist that combines bronchodilator activity with the sensory afferent modulating effects associated with D2-receptor agonism. Investigation in animal models...
7.
Hakkinen A, Sokka T, Kotaniemi A, Kautiainen H, Jappinen I, Laitinen L, et al.
J Rheumatol
. 1999 Jun;
26(6):1257-63.
PMID: 10381039
Objective: To assess the effects of 12 months' dynamic strength training on muscle strength and bone mineral density (BMD) at the lumbar spine and femoral neck in patients with early...
8.
Hakkinen A, Malkia E, Hakkinen K, Jappinen I, Laitinen L, Hannonen P
Br J Rheumatol
. 1997 Dec;
36(10):1075-81.
PMID: 9374924
The effects of detraining subsequent to strength training on neuromuscular function were examined in 39 recent-onset rheumatoid arthritis (RA) patients. Eighteen age- and sex-matched healthy people (H) served as controls....
9.
Leivo I, Tani T, Laitinen L, Bruns R, Kivilaakso E, Lehto V, et al.
J Histochem Cytochem
. 1996 Nov;
44(11):1267-77.
PMID: 8918902
Anchoring complex component laminin-5 and its subunits laminin (Ln)-alpha3 and Ln-beta3 chains, Type VII collagen, and integrin chains alpha3, alpha6, and beta4 were studied in developing and adult human intestine...
10.
Tani T, Laitinen L, Kangas L, Lehto V, Virtanen I
Int J Cancer
. 1995 Dec;
64(6):407-14.
PMID: 8550243
E- and N-cadherins are proteins involved in intercellular adhesion and are localized, e.g., in the adherens junctions of epithelial cells. Kidney tubules express these molecules in a distinctive pattern, the...